These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 8819510

  • 1. Effects of a nonpeptide endothelin-1 ETA antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system.
    Cameron NE, Cotter MA.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1262-8. PubMed ID: 8819510
    [Abstract] [Full Text] [Related]

  • 2. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
    Cameron NE, Cotter MA.
    Diabetes Metab Res Rev; 2002 Sep; 18(4):315-23. PubMed ID: 12203947
    [Abstract] [Full Text] [Related]

  • 3. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA, Cameron NE, Hohman TC.
    J Peripher Nerv Syst; 1998 Sep; 3(3):217-23. PubMed ID: 10959252
    [Abstract] [Full Text] [Related]

  • 4. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
    Nangle MR, Gibson TM, Cotter MA, Cameron NE.
    Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
    [Abstract] [Full Text] [Related]

  • 5. Effects of an extracellular metal chelator on neurovascular function in diabetic rats.
    Cameron NE, Cotter MA.
    Diabetologia; 2001 May; 44(5):621-8. PubMed ID: 11380081
    [Abstract] [Full Text] [Related]

  • 6. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [Abstract] [Full Text] [Related]

  • 7. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
    Cameron NE, Cotter MA.
    Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
    [Abstract] [Full Text] [Related]

  • 8. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME, Cotter MA, Cameron NE.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):63-71. PubMed ID: 17291486
    [Abstract] [Full Text] [Related]

  • 9. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.
    Cameron NE, Dines KC, Cotter MA.
    Diabetologia; 1994 Dec 30; 37(12):1209-15. PubMed ID: 7895950
    [Abstract] [Full Text] [Related]

  • 10. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK, Kumar H S A, Sharma SS.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):164-72. PubMed ID: 17521626
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist.
    Maxfield EK, Love A, Cotter MA, Cameron NE.
    Am J Physiol; 1995 Sep 30; 269(3 Pt 1):E530-7. PubMed ID: 7573431
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E.
    Skalska S, Kyselova Z, Gajdosikova A, Karasu C, Stefek M, Stolc S.
    Gen Physiol Biophys; 2008 Jun 30; 27(2):106-14. PubMed ID: 18645225
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ.
    Diabetes Metab Res Rev; 2003 Jun 30; 19(6):469-77. PubMed ID: 14648806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.